AERIE PHARMACEUTICALS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2012 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Aerie Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2012 to Q3 2022.
  • Aerie Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$26.8M, a 32.4% increase year-over-year.
  • Aerie Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$36.6M, a 78% increase year-over-year.
  • Aerie Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$74.8M, a 59.1% increase from 2020.
  • Aerie Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2020 was -$183M, a 8.26% increase from 2019.
  • Aerie Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2019 was -$200M, a 14.2% increase from 2018.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$36.6M -$26.8M +$12.9M +32.4% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-04
Q2 2022 -$49.4M -$19.4M +$19.3M +49.9% Apr 1, 2022 Jun 30, 2022 10-Q 2022-11-04
Q1 2022 -$68.7M -$35.9M +$6.07M +14.5% Jan 1, 2022 Mar 31, 2022 10-Q 2022-11-04
Q4 2021 -$74.8M $45.5M +$91.7M Oct 1, 2021 Dec 31, 2021 10-K 2022-02-25
Q3 2021 -$166M -$39.7M -$43K -0.11% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$166M -$38.7M +$9.5M +19.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-04
Q1 2021 -$176M -$42M +$7.17M +14.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-04
Q4 2020 -$183M -$46.1M +$8.93M +16.2% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-26
Q3 2020 -$192M -$39.6M +$9.75M +19.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$202M -$48.2M -$1.02M -2.17% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-05
Q1 2020 -$201M -$49.1M -$1.18M -2.46% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-05
Q4 2019 -$200M -$55.1M -$3.61M -7.01% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 -$196M -$49.4M +$36M +42.1% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-26
Q2 2019 -$232M -$47.2M +$7.86M +14.3% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-26
Q1 2019 -$240M -$48M -$7.25M -17.8% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-26
Q4 2018 -$233M -$51.5M +$7.06M +12.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-24
Q3 2018 -$240M -$85.4M -$53M -164% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-24
Q2 2018 -$187M -$55M -$26.6M -93.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-24
Q1 2018 -$160M -$40.7M -$14.9M -57.8% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-24
Q4 2017 -$145M -$58.5M -$29.2M -99.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$116M -$32.4M -$8.56M -35.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 -$107M -$28.4M -$5.21M -22.5% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 -$102M -$25.8M -$3.08M -13.6% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 -$99.1M -$29.3M -$8.95M -43.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 -$90.1M -$23.8M -$5.85M -32.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$84.3M -$23.2M -$4.43M -23.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$79.8M -$22.7M -$5.47M -31.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$74.4M -$20.4M -$3.88M -23.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 -$70.5M -$18M -$4.81M -36.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$65.7M -$18.8M -$6.97M -59% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$58.7M -$17.2M -$10.6M -158% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 -$48.1M -$16.5M -$6.22M -60.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-09
Q3 2014 -$41.9M -$13.1M -$2.4M -22.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$39.5M -$11.8M -$5.49M -86.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$34M -$6.67M -$2.88M -76% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$31.1M -$10.3M Oct 1, 2013 Dec 31, 2013 10-K 2016-03-02
Q3 2013 -$10.7M -$7.16M -199% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$6.33M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$3.79M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q3 2012 -$3.59M Jul 1, 2012 Sep 30, 2012 10-Q 2013-12-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.